Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing MedNews DeskApril 27, 20260 An experimental Intellia Therapeutics medicine that uses CRISPR technology to edit genes inside patients led to a significant reduction in…